163 related articles for article (PubMed ID: 31109257)
1. Role of RUNX2 transcription factor in epithelial mesenchymal transition in non-small cell lung cancer lung cancer: Epigenetic control of the RUNX2 P1 promoter.
Herreño AM; Ramírez AC; Chaparro VP; Fernandez MJ; Cañas A; Morantes CF; Moreno OM; Brugés RE; Mejía JA; Bustos FJ; Montecino M; Rojas AP
Tumour Biol; 2019 May; 41(5):1010428319851014. PubMed ID: 31109257
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of Nemo‑like kinase promotes metastasis in non‑small‑cell lung cancer.
Shi C; Xu L; Tang Z; Zhang W; Wei Y; Ni J; Zhang S; Feng J
Oncol Rep; 2019 Sep; 42(3):1090-1100. PubMed ID: 31322229
[TBL] [Abstract][Full Text] [Related]
3. Mll-COMPASS complexes mediate H3K4me3 enrichment and transcription of the osteoblast master gene Runx2/p57 in osteoblasts.
Rojas A; Sepulveda H; Henriquez B; Aguilar R; Opazo T; Nardocci G; Bustos F; Lian JB; Stein JL; Stein GS; van Zundert B; van Wijnen AJ; Allende ML; Montecino M
J Cell Physiol; 2019 May; 234(5):6244-6253. PubMed ID: 30256410
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of the TGFβ Pseudoreceptor BAMBI in Non-Small Cell Lung Cancer Enhances TGFβ Signaling and Invasion.
Marwitz S; Depner S; Dvornikov D; Merkle R; Szczygieł M; Müller-Decker K; Lucarelli P; Wäsch M; Mairbäurl H; Rabe KF; Kugler C; Vollmer E; Reck M; Scheufele S; Kröger M; Ammerpohl O; Siebert R; Goldmann T; Klingmüller U
Cancer Res; 2016 Jul; 76(13):3785-801. PubMed ID: 27197161
[TBL] [Abstract][Full Text] [Related]
5. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
Li X; Han J; Zhu H; Peng L; Chen Z
Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.
Sepulveda H; Aguilar R; Prieto CP; Bustos F; Aedo S; Lattus J; van Zundert B; Palma V; Montecino M
J Cell Physiol; 2017 Sep; 232(9):2519-2527. PubMed ID: 27689934
[TBL] [Abstract][Full Text] [Related]
7. PP4R1 interacts with HMGA2 to promote non-small-cell lung cancer migration and metastasis via activating MAPK/ERK-induced epithelial-mesenchymal transition.
Wang B; Pan LY; Kang N; Shen XY
Mol Carcinog; 2020 May; 59(5):467-477. PubMed ID: 32077156
[TBL] [Abstract][Full Text] [Related]
8. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
Lu C; Shan Z; Hong J; Yang L
Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of microRNA-137 expression by Slug promotes tumor invasion and metastasis of non-small cell lung cancer cells through suppression of TFAP2C.
Chang TH; Tsai MF; Gow CH; Wu SG; Liu YN; Chang YL; Yu SL; Tsai HC; Lin SW; Chen YW; Kuo PY; Yang PC; Shih JY
Cancer Lett; 2017 Aug; 402():190-202. PubMed ID: 28610956
[TBL] [Abstract][Full Text] [Related]
11. Silencing of RAD51AP1 suppresses epithelial-mesenchymal transition and metastasis in non-small cell lung cancer.
Wu Y; Wang H; Qiao L; Jin X; Dong H; Wang Y
Thorac Cancer; 2019 Sep; 10(9):1748-1763. PubMed ID: 31317661
[TBL] [Abstract][Full Text] [Related]
12. The human NANOS3 gene contributes to lung tumour invasion by inducing epithelial-mesenchymal transition.
Grelet S; Andries V; Polette M; Gilles C; Staes K; Martin AP; Kileztky C; Terryn C; Dalstein V; Cheng CW; Shen CY; Birembaut P; Van Roy F; Nawrocki-Raby B
J Pathol; 2015 Sep; 237(1):25-37. PubMed ID: 25904364
[TBL] [Abstract][Full Text] [Related]
13. Comparison of cofilin‑1 and Twist‑1 protein expression in human non‑small cell lung cancer tissues.
Chang CY; Chang SL; Leu JD; Chang YC; Hsiao M; Lin LT; Lin HN; Lee YJ
Oncol Rep; 2019 Aug; 42(2):805-816. PubMed ID: 31233187
[TBL] [Abstract][Full Text] [Related]
14. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Control of the Bone-master Runx2 Gene during Osteoblast-lineage Commitment by the Histone Demethylase JARID1B/KDM5B.
Rojas A; Aguilar R; Henriquez B; Lian JB; Stein JL; Stein GS; van Wijnen AJ; van Zundert B; Allende ML; Montecino M
J Biol Chem; 2015 Nov; 290(47):28329-28342. PubMed ID: 26453309
[TBL] [Abstract][Full Text] [Related]
16. TRIM47 overexpression is a poor prognostic factor and contributes to carcinogenesis in non-small cell lung carcinoma.
Han Y; Tian H; Chen P; Lin Q
Oncotarget; 2017 Apr; 8(14):22730-22740. PubMed ID: 28186994
[TBL] [Abstract][Full Text] [Related]
17. Runx2 mediates epigenetic silencing of the bone morphogenetic protein-3B (BMP-3B/GDF10) in lung cancer cells.
Tandon M; Gokul K; Ali SA; Chen Z; Lian J; Stein GS; Pratap J
Mol Cancer; 2012 Jun; 11():27. PubMed ID: 22537242
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-196b Inhibits Cell Growth and Metastasis of Lung Cancer Cells by Targeting Runx2.
Bai X; Meng L; Sun H; Li Z; Zhang X; Hua S
Cell Physiol Biochem; 2017; 43(2):757-767. PubMed ID: 28950255
[TBL] [Abstract][Full Text] [Related]
19. BOK displays cell death-independent tumor suppressor activity in non-small-cell lung carcinoma.
Moravcikova E; Krepela E; Donnenberg VS; Donnenberg AD; Benkova K; Rabachini T; Fernandez-Marrero Y; Bachmann D; Kaufmann T
Int J Cancer; 2017 Nov; 141(10):2050-2061. PubMed ID: 28744854
[TBL] [Abstract][Full Text] [Related]
20. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
